HIV delta 4 vaccine

Drug Profile

HIV delta 4 vaccine

Latest Information Update: 13 Jul 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator New England Regional Primate Center
  • Developer International Association of Physicians in Aids Care; New England Regional Primate Center
  • Class AIDS vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV-1 infections

Most Recent Events

  • 13 Jul 2001 Discontinued-Preclinical for HIV-1 infections in USA (Unknown route)
  • 13 Mar 1998 New profile
  • 13 Mar 1998 Preclinical development for HIV-1 infections in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top